P Tani
- Hematology top 0.5%
- Platelet Disorders and Treatments 30
- Blood groups and transfusion 16
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 8
-
- Autoimmune Bullous Skin Diseases 16
- Nephrology top 10%
- Renal Diseases and Glomerulopathies 6
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 3
-
- Tuberculosis Research and Epidemiology 4
-
- Heparin-Induced Thrombocytopenia and Thrombosis 3
P Tani
43 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 72
- Hematology 1.1k
- Immunology and Allergy 211
- Pathology and Forensic Medicine 315
- Nephrology 78
- Immunology 228
Countries citing papers authored by P Tani
This map shows the geographic impact of P Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Tani more than expected).
Fields of papers citing papers by P Tani
This network shows the impact of papers produced by P Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Tani. The network helps show where P Tani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside P Tani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 93 | |
| 2 | 2002 | 65 | |
| 3 | 1999 | 53 | |
| 4 | 1996 | 31 | |
| 5 | 1995 | 18 | |
| 6 | 1992 | 9 | |
| 7 | 1992 | 26 | |
| 8 | 1991 | 23 | |
| 9 | 1989 | 17 | |
| 10 | 1989 | 8 | |
| 11 | 1989 | 30 | |
| 12 | 1987 | 20 | |
| 13 | 1987 | 1 | |
| 14 | 1984 | 23 | |
| 15 | 1982 | 15 | |
| 16 | Medical and social aspects of chronic pulmonary tuberculosis in Finland. | 1970 | 0 |
| 17 | NON-TUBERCULOUS PLEURISY. | 1964 | 2 |
| 18 | CORTISONE THERAPY FOR EXUDATIVE TUBERCULOUS PLEURISY IN THE LIGHT OF A FOLLOW-UP STUDY. | 1964 | 21 |
| 19 | SIDE EFFECTS OF AN ANTITUBERCULOUS FIVE-DRUG REGIMEN: ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID. | 1963 | 0 |
| 20 | A study of patients with a long history of pulmonary tuberculosis. | 1963 | 2 |
About P Tani
P Tani is a scholar working on Hematology, Immunology and Allergy, Pathology and Forensic Medicine, Nephrology and Biochemistry, having authored 46 papers that have together received 1.4k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (30 papers), Autoimmune Bullous Skin Diseases (16 papers), Blood groups and transfusion (16 papers), Cell Adhesion Molecules Research (8 papers), Renal Diseases and Glomerulopathies (6 papers), Tuberculosis Research and Epidemiology (4 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Hematology (1.1k citations), Immunology and Allergy (211 citations), Pathology and Forensic Medicine (315 citations), Nephrology (78 citations) and Immunology (228 citations). P Tani has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Robert McMillan, Peter Berchtold, K Fujisawa, Frederick Millard, Ron D. Bowditch, VL Jr Woods, Lance C. Bridges, GL Dale, Lawrence D. Piro and TE O'Toole. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Biological Chemistry, Journal of Thrombosis and Haemostasis and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.